<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Many studies have demonstrated that <z:mpath ids='MPATH_3'>apoptosis</z:mpath> play an important role in cerebral ischemic pathogenesis and may represent a target for treatment </plain></SENT>
<SENT sid="1" pm="."><plain>Neuroprotective effect of <z:chebi fb="0" ids="16243">quercetin</z:chebi> has been shown in a variety of brain injury models including <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion </plain></SENT>
<SENT sid="2" pm="."><plain>It is not clear whether BDNF-TrkB-PI3K/Akt signaling pathway mediates the neuroprotection of <z:chebi fb="0" ids="16243">quercetin</z:chebi>, though there has been some reports on the <z:chebi fb="0" ids="16243">quercetin</z:chebi> increased brain-derived neurotrophic factor (BDNF) level in brain injury models </plain></SENT>
<SENT sid="3" pm="."><plain>We therefore first examined the neurological function, <z:mpath ids='MPATH_124'>infarct</z:mpath> volume and cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in <z:chebi fb="0" ids="16243">quercetin</z:chebi> treated middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) rats </plain></SENT>
<SENT sid="4" pm="."><plain>Then the protein expression of BDNF, cleaved caspase-3 and p-Akt were evaluated in either the absence or presence of PI3K inhibitor (LY294002) or tropomyosin receptor kinase B (TrkB) receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> (K252a) by immunohistochemistry staining and western blotting </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="0" ids="16243">Quercetin</z:chebi> significantly improved neurological function, while it decreased the <z:mpath ids='MPATH_124'>infarct</z:mpath> volume and the number of TdT mediated <z:chebi fb="0" ids="17625">dUTP</z:chebi> nick end labeling positive cells in MCAO rats </plain></SENT>
<SENT sid="6" pm="."><plain>The protein expression of BDNF, TrkB and p-Akt also increased in the <z:chebi fb="0" ids="16243">quercetin</z:chebi> treated rats </plain></SENT>
<SENT sid="7" pm="."><plain>However, treatment with LY294002 or K252a reversed the <z:chebi fb="0" ids="16243">quercetin</z:chebi>-induced increase of BDNF and p-Akt proteins and decrease of cleaved caspase-3 protein in focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> rats </plain></SENT>
<SENT sid="8" pm="."><plain>These results demonstrate that <z:chebi fb="0" ids="16243">quercetin</z:chebi> can decrease cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in the focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> rat brain and the mechanism may be related to the activation of BDNF-TrkB-PI3K/Akt signaling pathway </plain></SENT>
</text></document>